Esperion Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$3.87(as of Dec 9, 10:15 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Esperion Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$3.87
Ticker SymbolESPR
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees304
CountyUSA
Market Cap$884.3M
EBIDTA-29.3M
10-Day Moving Average3.74
P/E Ratio-7.32
20-Day Moving Average3.34
Forward P/E Ratio8.29
50-Day Moving Average3.01
Earnings per Share-0.54
200-Day Moving Average1.87
Profit Margin-35.89%
RSI66.83
Shares Outstanding237.1M
ATR0.24
52-Week High4.03
Volume5,626,840
52-Week Low0.69
Most Recent Support Level3.68
Book Value-451.4M
Most Recent Resistance Level3.91
P/B Ratio-1.72
Upper Keltner3.87
P/S Ratio2.55
Lower Keltner2.80
Debt-to-Equity Ratio3.87
Next Earnings Date02/24/2026
Cash Surplus-266.6M
Next Ex-Dividend DateUnknown

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease who require additional lowering of LDL-C. Its products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. It has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

Esperion Therapeutics Inc In Our Stock Scanner

As of Dec 09, 2025
example chart graphic
Scan Name: Bullish PennantScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Uptrending StocksScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.